120846-54-0

Upstream product

• 113832-57-8 N-(ethylidene)-cyclohexylamine 
• 118559-10-7 3,3-bis(4-fluorophenyl)-2-(1-methylethyl)propenal 
• 345-92-6 4,4'-Difluorobenzophenone 
• 118559-11-8 (E)-4-[Bis-(4-fluoro-phenyl)-methylene]-5-methyl-hex-2-enenitrile 
• 118559-07-2 ethyl 3,3-bis(4-fluorophenyl)-3-hydroxy-2-(1-methylethyl)-propionate 
• 118559-08-3 ethyl 3,3-bis(4-fluorophenyl)-2-(1-methylethyl)propenoate 
• 118559-09-4 2-di(4-fluorophenyl)methylene-3-methyl-1-butanol 

Downstream Products

• 120925-84-0 (E)-8-[Bis-(4-fluoro-phenyl)-methylene]-5-hydroxy-9-methyl-3-oxo-dec-6-enoic acid ethyl ester 
• 118581-22-9 Sodium; (E)-(3S,5R)-8-[bis-(4-fluoro-phenyl)-methylene]-3,5-dihydroxy-9-methyl-dec-6-enoate 
• 118559-14-1 (E)-(3S,5R)-8-[Bis-(4-fluoro-phenyl)-methylene]-3,5-dihydroxy-9-methyl-dec-6-enoic acid ethyl ester 
• 118559-14-1 (E)-(3R,5R)-8-[Bis-(4-fluoro-phenyl)-methylene]-3,5-dihydroxy-9-methyl-dec-6-enoic acid ethyl ester 

Relevant academic research and scientific papers

Antihypercholesterolemic alkylene compounds

Compounds of the formula STR1 wherein R1, R2, R3 and R4 each are independently hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy or trifluoromethyl; R is C1-7 alkyl, C3-6 cyc

SYNTHESIS OF A NOVEL HMG-COA REDUCTASE INHIBITOR

The synthesis of a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor starting from 4,4'-difluorobenzophenone is described.